Grade: Pharmaceutical Grade

Factory Location: Quanzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Payment Terms: L/C

Cabazitaxel Jevtana is a microtubule inhibitor that is indicated in combination with Prednisone or Prednisolone for the treatment of hormone refractory metastatic prostate cancer in patients who have been treated with Docetaxel containing docetaxel. Carbataxel Jevtana can inhibit cancer cell growth and even cause cancer cell death. Clinical trials have shown that it can also shrink tumors and slow the growth or spread of tumors to relieve symptoms of prostate cancer and improve patients' quality of life.